Brimonidine Tartrate

Brimonidine tartrate is the active ingredient.It may contain inactive ingredients that vary depending on the formulation (e.g., preservatives, stabilizers).

Treatment of openangle glaucoma.

Treatment of ocular hypertension (elevated eye pressure).

Erythego Gel 15gm (Brimonidine Tartrate) is an alpha2-adrenergic agonist. It reduces intraocular pressure (IOP) by decreasing aqueous humor production and increasing uveoscleral outflow.

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children. Discard any unused medication after the expiration date.

Dosage and frequency are determined by your ophthalmologist.

Typically administered as eye drops.

Follow your doctor's instructions carefully.

Eye irritation (burning, stinging, redness)

Dry eyes

Blurred vision

Eyelid changes (ptosis, swelling)

Allergic reactions (rare)

Fatigue, drowsiness (systemic effects, less common)

Alcohol Consumption

No specific contraindications, but excessive alcohol use should be discussed with your physician.



While Driving or operating Machinery

May cause blurred vision or drowsiness. Avoid driving or operating machinery until vision is clear and any drowsiness subsides.



Pregnant & Breastfeeding Women

Use during pregnancy and breastfeeding is generally avoided unless the benefits clearly outweigh the potential risks. Consult your doctor.



Children

Safety and efficacy in children have not been established.



Kidney

Caution is advised in patients with severe renal impairment.



Liver

Caution is advised in patients with severe hepatic impairment.

Consult your doctor or pharmacist for detailed information.

Refer to the package insert for the specific product you are using.

Reliable medical websites (e.g., FDA, MedlinePlus).